Intel (INTC) will be reporting its latest round of earnings when markets close today. Shortly thereafter, the company will hold an earnings call to provide more information to shareholders. You can ...
Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.